These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Botulinum toxin injection for production of ptosis]. Merté RL; Lanzl IM Ophthalmologe; 2007 Sep; 104(9):767-70. PubMed ID: 17846779 [TBL] [Abstract][Full Text] [Related]
9. The use of apraclonidine eyedrops to treat ptosis after the administration of botulinum toxin to the upper face. Scheinfeld N Dermatol Online J; 2005 Mar; 11(1):9. PubMed ID: 15748550 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic use of botulinum toxin in patients with Duane syndrome. Dawson EL; Maino A; Lee JP Strabismus; 2010 Mar; 18(1):21-3. PubMed ID: 20230203 [TBL] [Abstract][Full Text] [Related]
11. [Botulinum toxin injection-treatment of upper lid retraction in thyroid eye disease]. Dintelmann T; Sold J; Grehn F Ophthalmologe; 2005 Mar; 102(3):247-50. PubMed ID: 15322802 [TBL] [Abstract][Full Text] [Related]
12. Persistence of Upper Blepharoptosis After Cosmetic Botulinum Toxin Type A. Steinsapir KD; Groth MJ; Boxrud CA Dermatol Surg; 2015 Jul; 41(7):833-40. PubMed ID: 26057409 [TBL] [Abstract][Full Text] [Related]
13. [Botulinum toxin A induced protective ptosis for the treatment of recurrent epithelial defects in neurotrophic keratopathy]. Schilimow A; Wiechens B Ophthalmologe; 2017 Aug; 114(8):745-747. PubMed ID: 27766386 [TBL] [Abstract][Full Text] [Related]
14. Anterior chemodenervation of levator palpebrae superioris with botulinum toxin type-A (Botox) to induce temporary ptosis for corneal protection. Naik MN; Gangopadhyay N; Fernandes M; Murthy R; Honavar SG Eye (Lond); 2008 Sep; 22(9):1132-6. PubMed ID: 17510652 [TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin A in blepharospasm and hemifacial spasm. Behari M; Singh KK; Seshadri S; Prasad K; Ahuja GK J Assoc Physicians India; 1994 Mar; 42(3):205-8. PubMed ID: 7860509 [TBL] [Abstract][Full Text] [Related]
16. [Cornea protection in ptosis induced by botulinum injection]. Brans JW; Aramideh M; Schlingemann RO; Oen VM; Speelman JD; Ongerboer de Visser BW Ned Tijdschr Geneeskd; 1996 May; 140(19):1031-3. PubMed ID: 8684496 [TBL] [Abstract][Full Text] [Related]
17. Apraclonidine in the treatment of ptosis. Wijemanne S; Vijayakumar D; Jankovic J J Neurol Sci; 2017 May; 376():129-132. PubMed ID: 28431598 [TBL] [Abstract][Full Text] [Related]
18. Factors influencing success and dose-effect relation of botulinum A treatment. Abbasoglu OE; Sener EC; Sanac AS Eye (Lond); 1996; 10 ( Pt 3)():385-91. PubMed ID: 8796167 [TBL] [Abstract][Full Text] [Related]
19. Levator aponeurosis dehiscence in a patient treated with botulinum toxin for blepharospasms and eyelid apraxia. Verhulst S; Smet H; De Wilde F; Tassignon MJ Bull Soc Belge Ophtalmol; 1994; 252():51-3. PubMed ID: 7894756 [TBL] [Abstract][Full Text] [Related]
20. Unilateral ptosis: a rare presentation. Farooq S; Dukht U; Jaffar S J Pak Med Assoc; 2009 May; 59(5):319-21. PubMed ID: 19438140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]